Feasibility Study of Biomarker Development for Response Prediction by Large Scale DNA Mutational Analysis of Metastatic Lesions
Observational
Observational Model: Cohort, Time Perspective: Prospective
Exploration of the correlation between the mutational profile and the percentage change in volumetric measurement of the index lesion after the first two cycles of chemotherapy.
Change in radiological volume of the index lesion after the first 2 cycles of irinotecan. Radiological response (according to RECIST 1.1) after the first 2 cycles of irinotecan (i.e. after 2 x 3 weeks = 6 weeks)
No
Miriam Koopman, MD/PhD
Principal Investigator
UMC Utrecht
Netherlands: Medical Ethics Review Committee (METC)
NL35198.041.11
NCT01855061
May 2011
May 2014
Name | Location |
---|